---
category: news
title: "Bayer pays $310m for Euro rights to ATTR therapy acoramidis"
excerpt: "Bayer has shored up its near-term pipeline by acquiring European rights to acoramidis from BridgeBio and Eidos Therapeutics, putting some big pharma muscle behind the therapy for transthyretin ... he added. Artificial intelligence (AI) has become an ..."
publishedDateTime: 2024-03-04T00:00:00Z
originalUrl: "https://pharmaphorum.com/news/bayer-pays-310m-euro-rights-attr-therapy-acoramidis"
webUrl: "https://pharmaphorum.com/news/bayer-pays-310m-euro-rights-attr-therapy-acoramidis"
type: article
quality: 39
heat: 39
published: false

provider:
  name: pharmaphorum
  domain: pharmaphorum.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pharmaphorum.com/sites/default/files/2024-03/Bayer_cross%20_Leverkusen%20_night_960x540.jpg"
    width: 960
    height: 540
    isCached: true

secured: "qreRz/8Tuf7wdqNfmS2RQHhBVDZHSMfOarr7ZPC6lRT4Up/ctinjpGuq4i51W5v4dIIrZCMZWJcEjp/tH82kAvFjM6DsCA99C8DCf58CG5/hEV8RT9F4c1qdN3cEhxTTJFurPy6QiWDOguHy0IhPRlA6Ah+bnX0+PhFn+mYyA2Y2/Z3hhHAXlwMIwEA51j7u+BL5S8ZrjAz538A6hONbWGNj3ElFbihfvuvNlpHJRJjz6iRBIcZKBcvWPFtbko2ZEgFjaYf0k0EZA/Gmrlc2qEbHRbQoIYznDequiLW6Cq816QCRB6mMCV9dUw9eOc1/y9nXF+HFwhQOrdcpoq6AlrXpXQdVQZeAhyazZUIZos0=;QqVQyOx6QP+KxC++0YzNXg=="
---

